Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CYLD deubiquitinates CDKN2C. 3 / 3

| 3

➶

reach

"Knockdown of CYLD significantly increased the polyubiquitylation of p18, whereas, overexpression of CYLD reduced the levels of polyubiquitylation of p18."

33654169

➶

reach

"As expected, CYLD decreased p18 polyubiquitylation in vitro."

33654169

➶

reach

"These data indicate that CYLD directly deubiquitylates p18."

33654169

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

CYLD deubiquitinates CDKN2C. 3 / 3

Our Sources:

Databases

Reading